Advertisement

AIDS and Behavior

, Volume 21, Issue 11, pp 3182–3193 | Cite as

Lessons Learned From the Implementation of Seek, Test, Treat, Retain Interventions Using Mobile Phones and Text Messaging to Improve Engagement in HIV Care for Vulnerable Populations in the United States

  • Katerina A. Christopoulos
  • William E. Cunningham
  • Curt G. Beckwith
  • Irene Kuo
  • Carol E. Golin
  • Kevin Knight
  • Patrick M. Flynn
  • Anne C. Spaulding
  • Lara S. Coffin
  • Bridget Kruszka
  • Ann Kurth
  • Jeremy D. Young
  • Sharon Mannheimer
  • Heidi M. Crane
  • Shoshana Y. Kahana
Original Paper

Abstract

In the United States, little is known about interventions that rely on mobile phones and/or text messaging to improve engagement in HIV care for vulnerable populations. Domestic studies using these technologies as part of the National Institute on Drug Abuse “Seek, Test, Treat, Retain” research initiative were queried regarding intervention components, implementation issues, participant characteristics, and descriptive statistics of mobile phone service delivery. Across five studies with 1,135 predominantly male, minority participants, implementation challenges occurred in three categories: (1) service interruptions; (2) billing/overage issues, and; (3) the participant user experience. Response rules for automated text messages frequently frustrated participants. The inability to reload minutes/texting capacity remotely was a significant barrier to intervention delivery. No study encountered confidentiality breaches. Service interruption was common, even if studies provided mobile phones and plans. Future studies should attend to the type of mobile phone and service, the participant user experience, and human subjects concerns.

Keywords

mHealth SMS Text messaging Retention in HIV care Engagement in HIV care 

Resumen

Existe poca información acerca de las intervenciones que utilizan teléfonos móviles y/o mensajes de texto para mejorar el cuidado de VIH en poblaciones vulnerables. Estudios nacionales que utilizan estas tecnologías como parte de la iniciativa sobre la “búsqueda, prueba, tratamiento, retención” del Instituto Nacional sobre el Abuso de Drogas describieron los componentes de la intervención, los aspectos de la implementación, las características de los participantes, y las estadísticas descriptivas relacionadas con el uso de teléfonos móviles. Cinco estudios, con un total de 1.135 participantes predominantemente masculinos y minoritarios, expresaron desafíos de implementación en tres categorías: (1) interrupciones de servicio; (2) problemas de facturación/rebasamiento; y; (3) las experiencias de uso del participante. Las reglas automatizadas en las respuestas de mensajes frustraron a los participantes frecuentemente. La inhabilidad de recargar remotamente los minutos/mensajes de texto fueron una barrera significativa para suministrar la intervención de forma consistente. Es importante destacar que ningún estudio encontró violaciones de confidencialidad. La interrupción del servicio fue común, incluso para los estudios que proporcionaban teléfonos móviles y planes a sus participantes. Futuros estudios deben atender al tipo de teléfono móvil y servicio, las experiencias de uso del participante, y consideraciones sobre la protección de los participantes en la investigación.

Notes

Acknowledgements

The authors would like to acknowledge Terence Johnson for assistance in assembling the cost data.

Funding

Funded by National Institutes of Health R01 DA032057, R01 DA030781, R01 DA030747, R01 DA030793, R34 DA035728.

Compliance with Ethical Standards

Conflict of interest

Dr. Christopoulos has been a scientific advisory board member for Roche and a community advisory board member for Gilead. No other conflicts of interest reported.The opinions in this article are those of the authors and do not necessarily reflect official positions of the National Institute on Drug Abuse, the National Institutes of Health, or the Department of Health and Human Services.

References

  1. 1.
    Reynolds NR, Testa MA, Su M, et al. Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. J Acquir Immune Defic Syndr. 2008;47:62–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Horvath T, Azman H, Kennedy GE, Rutherford GW. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. Cochrane Database Syst Rev. 2012;14:CD009756.Google Scholar
  3. 3.
    Lester RT, Ritvo P, Mills EJ, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376:1838–45.CrossRefPubMedGoogle Scholar
  4. 4.
    Pop-Eleches C, Thirumurthy H, Habyarimana JP, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25:825–34.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Mbuagbaw L, van der Kop ML, Lester RT, et al. Mobile phone text messages for improving adherence to antiretroviral therapy (ART): an individual patient data meta-analysis of randomised trials. BMJ Open. 2013;3:e003950.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Haberer JE, Musiimenta A, Atukunda EC, et al. Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. Aids. 2016;30:1295–300.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Garofalo R, Kuhns LM, Hotton A, Johnson A, Muldoon A, Rice D. A randomized controlled trial of personalized text message reminders to promote medication adherence among HIV-positive adolescents and young adults. AIDS Behav. 2016;20:1049–59.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Belzer ME, Kolmodin MacDonell K, Clark LF, et al. Acceptability and feasibility of a cell phone support intervention for youth living with hiv with nonadherence to antiretroviral therapy. AIDS Patient Care STDS. 2015;29:338–45.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Belzer ME, Naar-King S, Olson J, et al. The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial. AIDS Behav. 2014;18:686–96.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Dowshen N, Kuhns LM, Gray C, Lee S, Garofalo R. Feasibility of interactive text message response (ITR) as a novel, real-time measure of adherence to antiretroviral therapy for HIV+ youth. AIDS Behav. 2013;17:2237–43.CrossRefPubMedGoogle Scholar
  11. 11.
    Lewis MA, Uhrig JD, Bann CM, et al. Tailored text messaging intervention for HIV adherence: a proof-of-concept study. Health Psychol. 2013;32:248–53.CrossRefPubMedGoogle Scholar
  12. 12.
    Reback CJ, Ling D, Shoptaw S, Rohde J. Developing a text messaging risk reduction intervention for methamphetamine-using MSM: research note. Open AIDS J. 2010;4:116–22.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Reback CJ, Grant DL, Fletcher JB, et al. Text messaging reduces HIV risk behaviors among methamphetamine-using men who have sex with men. AIDS Behav. 2012;16:1993–2002.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Ingersoll K, Dillingham R, Reynolds G, et al. Development of a personalized bidirectional text messaging tool for HIV adherence assessment and intervention among substance abusers. J Subst Abuse Treat. 2014;46:66–73.CrossRefPubMedGoogle Scholar
  15. 15.
    Ingersoll KS, Dillingham RA, Hettema JE, et al. Pilot RCT of bidirectional text messaging for ART adherence among nonurban substance users with HIV. Health Psychol. 2015;34S:1305–15.CrossRefPubMedGoogle Scholar
  16. 16.
    Mayer JE, Fontelo P. Meta-analysis on the effect of text message reminders for HIV-related compliance. AIDS Care. 2017;29:409–17.CrossRefPubMedGoogle Scholar
  17. 17.
    Christopoulos KA, Riley ED, Tulsky J, et al. A text messaging intervention to improve retention in care and virologic suppression in a U.S. urban safety-net HIV clinic: study protocol for the Connect4Care (C4C) randomized controlled trial. BMC Infect Dis. 2014;14:718.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Norton BL, Person AK, Castillo C, Pastrana C, Subramanian M, Stout JE. Barriers to using text message appointment reminders in an HIV clinic. Telemed J E Health. 2014;20:86–9.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Rana AI, van den Berg JJ, Lamy E, Beckwith CG. Using a mobile health intervention to support HIV treatment adherence and retention among patients at risk for disengaging with care. AIDS Patient Care STDS. 2016;30:178–84.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Baillargeon J, Giordano TP, Rich JD, et al. Accessing antiretroviral therapy following release from prison. JAMA. 2009;301:848–57.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Althoff AL, Zelenev A, Meyer JP, et al. Correlates of retention in HIV care after release from jail: results from a multi-site study. AIDS Behav. 2013;17(Suppl 2):S156–70.CrossRefPubMedGoogle Scholar
  22. 22.
    Iroh PA, Mayo H, Nijhawan AE. The HIV care cascade before, during, and after incarceration: a systematic review and data synthesis. Am J Public Health. 2015;105:e5–16.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Dowdy DW, Geng EH, Christopoulos KA, et al. Mortality among antiretroviral-eligible patients in an urban public clinic. J Acquir Immune Defic Syndr. 2011;57:297–300.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Mugavero MJ, Lin HY, Allison JJ, et al. Racial disparities in HIV virologic failure: do missed visits matter? J Acquir Immune Defic Syndr. 2009;50:100–8.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Mugavero MJ, Westfall AO, Cole SR, et al. Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clin Infect Dis. 2014;59:1471–9.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Chandler RK, Kahana SY, Fletcher B, et al. Data collection and harmonization in HIV research: the seek, test, treat, and retain initiative at the national institute on Drug Abuse. Am J Public Health. 2015;105:2416–22.CrossRefPubMedGoogle Scholar
  27. 27.
    Kurth A, Kuo I, Peterson J, et al. Information and communication technology to link criminal justice reentrants to HIV care in the community. AIDS Res Treat. 2013;2013:547381.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Peterson J, Cota M, Gray H, et al. Technology use in linking criminal justice reentrants to HIV care in the community: a qualitative formative research study. J Health Commun. 2015;20:245–51.CrossRefPubMedGoogle Scholar
  29. 29.
    Golin CE, Knight K, Carda-Auten J, et al. Individuals motivated to participate in adherence, care and treatment (imPACT): development of a multi-component intervention to help HIV-infected recently incarcerated individuals link and adhere to HIV care. BMC Public Health. 2016;16:935.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Abroms LC, Whittaker R, Free C, Mendel Van Alstyne J, Schindler-Ruwisch JM. Developing and pretesting a text messaging program for health behavior change: recommended steps. JMIR Mhealth Uhealth. 2015;3:e107.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Iribarren SJ, Brown W 3rd, Giguere R, et al. Scoping review and evaluation of SMS/text messaging platforms for mHealth projects or clinical interventions. Int J Med Inform. 2017;101:28–40.CrossRefPubMedGoogle Scholar
  32. 32.
    Kalichman SC, Kalichman MO, Cherry C, Eaton LA, Cruess D, Schinazi RF. Randomized factorial trial of phone-delivered support counseling and daily text message reminders for HIV treatment adherence. J Acquir Immune Defic Syndr. 2016;73:47–54.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Finitsis DJ, Pellowski JA, Johnson BT. Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS ONE. 2014;9:e88166.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Wohl DA, Golin CE, Knight K, et al. Randomized controlled trial of an intervention to maintain suppression of HIV viremia after prison release: the imPACT trial. J Acquir Immune Defic Syndr. 2017;75:81–90.CrossRefPubMedGoogle Scholar
  35. 35.
    Freudenberg N, Daniels J, Crum M, Perkins T, Richie BE. Coming home from jail: the social and health consequences of community reentry for women, male adolescents, and their families and communities. Am J Public Health. 2005;95:1725–36.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Conklin TJ, Lincoln T, Tuthill RW. Self-reported health and prior health behaviors of newly admitted correctional inmates. Am J Public Health. 2000;90:1939–41.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Haley DF, Golin CE, Farel CE, et al. Multilevel challenges to engagement in HIV care after prison release: a theory-informed qualitative study comparing prisoners’ perspectives before and after community reentry. BMC Public Health. 2014;14:1253.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Binswanger IA, Nowels C, Corsi KF, et al. “From the prison door right to the sidewalk, everything went downhill,” a qualitative study of the health experiences of recently released inmates. Int J Law Psychiatry. 2011;34:249–55.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Katerina A. Christopoulos
    • 1
  • William E. Cunningham
    • 2
  • Curt G. Beckwith
    • 3
  • Irene Kuo
    • 4
  • Carol E. Golin
    • 5
  • Kevin Knight
    • 6
  • Patrick M. Flynn
    • 6
  • Anne C. Spaulding
    • 7
  • Lara S. Coffin
    • 1
  • Bridget Kruszka
    • 8
  • Ann Kurth
    • 9
  • Jeremy D. Young
    • 10
  • Sharon Mannheimer
    • 11
  • Heidi M. Crane
    • 12
  • Shoshana Y. Kahana
    • 13
  1. 1.Division of HIV, ID and Global Medicine, Zuckerberg San Francisco General HospitalUniversity of California San FranciscoSan FranciscoUSA
  2. 2.Departments of Medicine and Health Policy and ManagementUCLA Schools of Medicine and Public HealthLos AngelesUSA
  3. 3.Division of Infectious DiseasesWarren Alpert School of Medicine at Brown UniversityProvidenceUSA
  4. 4.Department of Epidemiology and Biostatistics, Milken Institute School of Public HealthGeorge Washington UniversityWashingtonUSA
  5. 5.Department of Health BehaviorUNC Gillings School of Global Public HealthChapel HillUSA
  6. 6.Institute of Behavioral ResearchTexas Christian UniversityFort WorthUSA
  7. 7.Department of EpidemiologyRollins School of Public Health, Emory UniversityAtlantaUSA
  8. 8.Collaborative Health Studies Coordinating CenterUniversity of WashingtonSeattleUSA
  9. 9.School of NursingYale UniversityNew HavenUSA
  10. 10.Division of Infectious DiseaseUniversity of Illinois at ChicagoChicagoUSA
  11. 11.Departments of Medicine and EpidemiologyColumbia UniversityNew YorkUSA
  12. 12.Division of Allergy and Infectious DiseasesUniversity of WashingtonSeattleUSA
  13. 13.Services Research BranchNational Institute on Drug AbuseBethesdaUSA

Personalised recommendations